AMNEAL PHARMACEUTICALS, INC. (AMRX) Revenue 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.0BFY2025 · since FY2016: $1.0B → $3.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.0B | +8.0% |
| FY2024 | $2.8B | +16.7% |
| FY2023 | $2.4B | +8.2% |
| FY2022 | $2.2B | +5.7% |
| FY2021 | $2.1B | +5.1% |
| FY2020 | $2.0B | +22.5% |
| FY2019 | $1.6B | -2.2% |
| FY2018 | $1.7B | +60.9% |
| FY2017 | $1.0B | +1.5% |
| FY2016 | $1.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice